• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 421295 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1416613976 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1416613976 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Stock Investors Bid Up Shares of Halozyme Therapeutics, Up 14.0%

Published on Mon, 01/14/2013 - 13:11
By Peter Chu

Up 14.0% to $8.22, Halozyme Therapeutics (NASDAQ:HALO), is one of today's notable movers. The S&P is trading lower by 0.2% to 1,469 and the Dow is trading fractionally higher to 13,494.

Halozyme Therapeutics, Inc. develops and commercializes recombinant human enzymes for the infertility, ophthalmology, and oncology communities. The Company's product portfolio is based on intellectual property covering the family of human enzymes known as hyaluronidases. Halozyme's products offer an alternative to slaughterhouse-derived extracts that carry contamination risks.

Halozyme Therapeutics has overhead space with shares priced $8.22, or 4.2% below the average consensus analyst price target of $8.58. The stock should discover initial support at its 200-day moving average (MA) of $7.35 and subsequent support at its 50-day MA of $5.92.

In the past 52 weeks, Halozyme Therapeutics share prices have been bracketed by a low of $3.86 and a high of $13.50 and are now at $8.22, 113% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 3.0% while the 200-day MA has slid 1.7%.

By Peter Chu
pchu@fnno.com

Latest News from FNNO

Whirlpool: 52-Week High Recently Eclipse...

Whirlpool (NYSE:WHR) traded at a new 52-week high today of $185.34. This new high was ...

Watch for Continued Gains in Shares of W...

Werner Enterprises (NASDAQ:WERN) traded at a new 52-week high today of $29.10. So far ...

Watch for Continued Gains in Shares of W...

Shares of Waters (NYSE:WAT) traded today at $117.71, breaking its 52-week high. This n ...

Wabtec: The Winning Streak Continues (WA...

Wabtec (NYSE:WAB) traded today at a new 52-week high of $90.98. Approximately 327,000 ...

Recent 52-Week High Exceeded in Shares o...

Verint Systems (NASDAQ:VRNT) traded at a new 52-week high today of $60.25. Approximate ...

Validus Holdings: The Winning Streak Con...

Validus Holdings (NYSE:VR) traded at a new 52-week high today of $41.28. This new high ...

Meridian Bioscience Looks to Continue to...

Shares of Meridian Bioscience (NASDAQ:VIVO) traded today at $15.80, breaking its 52-wee ...

Shares of VF Corp Have Risen Above Previ...

Shares of VF Corp (NYSE:VFC) traded today at $74.35, breaking its 52-week high. This n ...